M. Veltkamp (De Meern, Netherlands), A. Vorselaars (Nieuwegein, Netherlands)
Corticosteroid-induced remission, and mycophenolate maintenance therapy in GLILD: long-term, longitudinal change in lung function in a single centre cohort H. Bintalib (London, United Kingdom), D. Lowe (London, United Kingdom), G. Mancuso (Milan, Italy), G. Gkrepi (Ioannina, Greece), S. Seneviratne (London, United Kingdom), S. Burns (London, United Kingdom), J. Hurst (London, United Kingdom)
| |
Modifiable lifestyle factors for sarcoidosis: a nested case-control study M. Dehara (Stockholm, Sweden), M. Sacks (Stockholm, Sweden), J. Grunewald (Stockholm, Sweden), A. Blomberg (Umeå, Sweden), E. Arkema (Stockholm, Sweden)
| |
Cardiac involvement in sarcoidosis patients: which patients should be screened? E. Naz Ertürk (Mersin, Turkey), B. Ulubas (Mersin, Turkey), K. Esen (Mersin, Turkey), A. Çelik (Mersin, Turkey), S. Balci (Mersin, Turkey), L. Tamer (Mersin, Turkey)
| |
Diagnosing Small Fiber Neuropathy in Sarcoidosis remains challenging L. Raasing (Nieuwegein, Netherlands), M. Veltkamp (Nieuwegein, Netherlands), O. Vogels (Nieuwegein, Netherlands), J. Grutters (Utrecht, Netherlands)
| |
Long-term outcomes of combination therapy with methotrexate and methylprednisolone in patients with pulmonary sarcoidosis I. Merenkova (Kyiv, Ukraine), V. Gavrysyuk (Kyiv, Ukraine), Y. Dziublyk (Kyiv, Ukraine), G. Gumeniuk (Kyiv, Ukraine), N. Pendalchuk (Kyiv, Ukraine), D. Butov (Kharkiv, Ukraine)
| |
Sarcoid-like reaction with mediastinal lymphadenopathy in patients after breast cancer surgery R. Imai (Tokyo, Japan), Y. Tsuchida (Tokyo, Japan), T. Jinta (Tokyo, Japan)
| |
Bone mineral density in Danish patients with sarcoidosis J. Møller (Aarhus, Denmark), L. Rejnmark (Aarhus, Denmark), E. Bendstrup (Aarhus, Denmark)
| |
Vasoactive intestinal peptide for granulomatous diseases – a case series. B. Frye (Freiburg, Germany), C. Gutzler (Freiburg, Germany), G. Zissel (Freiburg, Germany), K. Höhne (Freiburg, Germany), J. Müller-Quernehim (Freiburg, Germany)
| |
Doppler resistive index is informative for assessment lymph nodes on EBUS for predictive diagnosis of sarcoidosis R. Bubnov (Kyiv, Ukraine), A. Serhiienko (Kyiv, Ukraine)
| |
The association between respiratory muscles and physical functioning in patients with ILD: Preliminary results T. Zlámalová (Olomouc, Czech Republic), M. Dvoracek (Olomouc, Czech Republic), S. Breuls (Leuven, Belgium), H. Demeyer (Leuven, Belgium), T. Troosters (Leuven, Belgium), M. Zurkova (Olomouc, Czech Republic), K. Neumannova (Olomouc, Czech Republic)
| |
Polymorphisms in immune related genes are associated with Sarcoidosis in Korean Population K. Sikorová (Olomouc, Czech Republic), H. Yoon (Seoul, Republic of Korea), A. Strnad (Olomouc, Czech Republic), L. Kocourková (Olomouc, Czech Republic), S. Moon (Seoul, Republic of Korea), J. Song (Seoul, Republic of Korea), M. Petrek (Olomouc, Czech Republic)
| |
Sarcoidosis, from bioinformatics to bench work T. El Jammal (Lyon, France), F. Chevalier (Lyon, France), P. Sève (Lyon, France), Y. Pachéco (Lyon, France), A. Calender (Lyon, France)
| |
Covid-19 infection in patients with sarcoidosis: clinical course and outcome – single center experience M. Batarilo Hadar (Zagreb, Croatia), M. Jankovic Makek (Zagreb, Croatia), F. Džubur (Zagreb, Croatia), D. Mihelcic Korte (Zagreb, Croatia), D. Rnjak (Zagreb, Croatia), G. Pavliša (Zagreb, Croatia), A. Vukic Dugac (Zagreb, Croatia), M. Samaržija (Zagreb, Croatia), A. Hecimovic (Zagreb, Croatia)
| |
ANXA11 rs1049550 associates with Löfgren’s syndrome and chronic sarcoidosis patients B. Karakaya (Nieuwegein, Netherlands), J. Van Der Vis (Nieuwegein, Netherlands), M. Veltkamp (Nieuwegein, Netherlands), D. Biesma (Leiden, Netherlands), J. Grutters (Nieuwegein, Netherlands), C. Van Moorsel (Nieuwegein, Netherlands)
| |
Features of the course of COVID-19 in patients with sarcoidosis O. Semendyayeva (Mariupol, Ukraine), N. Monogarova (Mariupol, Ukraine), K. Borodiy (Mariupol, Ukraine), D. Stupachenko (Mariupol, Ukraine), D. Shevchenko (Mariupol, Ukraine)
| |